Recent advances in human embryonic stem cell (hESC) 
The derivation of human embryonic stem cell (hESC) lines in 1998 has generated great excitement in the fields of regenerative medicine and tissue engineering, for these cells possess the potential to provide a limitless supply of virtually all somatic cell types from a clonal source [1] . Culture practices that expand undifferentiated hESCs and methods to direct differentiation toward specific lineages are improving at a rapid pace, and researchers have begun to incorporate hESC derivatives into tissue engineering strategies. Here, we summarize the use of hESCs in tissue engineering applications, highlighting specific advantages hESC-derived cells provide over current practices that predominantly utilize primary cells. We also discuss potential pitfalls that may arise and must be addressed to successfully use hESCs in tissue engineering. In addition, progress toward the generation of specific tissues from hESCs or human adult progenitors will be described.
Stem cell tissue engineering
Tissue engineering can be broadly defined as the generation of biological substitutes that reproduce one or more functions of a particular tissue or organ [2] . Engineered tissue constructs can be used therapeutically or for diagnostic purposes, and examples range from acellular nanofibre peptide scaffolds [3] to fully cellularized skin grafts containing cells expanded from autologous skin [4] . The [5] and haematopoietic progenitors [6] [7] .
Potential cell sources

Current, cell-based tissue therapies utilize post-natal cell sources, but most cannot be expanded efficiently and cost-effectively in vitro. Many efforts have focused on improving methods of expanding somatic cell populations, including mesenchymal
In contrast to adult progenitors, hESCs can be maintained almost indefinitely in the undifferentiated state [1] [8] .
Incorporation of hESCs
Substantial advances in hESC culture and differentiation processes must be made before hESC-derived tissues can be successfully implemented in the clin
Incorporation of hESCs into engineered tissues will require a detailed understanding of how the cells interact with the various components that comprise engineered tissues. The complex interactions between hESCs and their microenvironment must be characterized to better control stem cell growth and differentiation [9] . While previous studies using adult progenitors [12] , and bone morphogenetic protein (BMP) signalling, which induces differentiation [13] . Wnt/␤-catenin signalling, a pathway often activated in cancer, has also recently been implicated in hESC proliferation and self-renewal [14] . Researchers have derived hESC lines using completely defined conditions, though these initial lines acquired karyotype abnormalities [15] [1, 13] Activin A [12] , bFGF [11, 13] , Wnt [14] Agarose gels [21] , polymeric hydrogels [26] , microwells [27, 28] Skin Keratinocytes p63, K5/K14 [42] RA, BMP [46] GAG [35] , collagen gel, organotypic culture [36, 41, 44] Cornea Corneal epithelia p63, K3/K12 [51] Not defined Nanotopography [48] , organotypic culture [50] Neural Neuroepithelia Domaminergic neurons Pax6, Sox1 [58] TH, AADC [53, 54] Noggin [53] FGF8, SHH [54] PLGA [59, 99] Motor neurons Oligodendrocytes HB9, ChAT [58] Sox10, O4, MBP [60, 61] RA, SHH [57, 58] RA, EGF, bFGF [60, 61] Peptide nanofibres [3] Bone marrow Mesenchymal progenitors Haematopoietic progenitors CD73 [80] CD43 [92] , CD34 [91] [92] [93] Not defined BMP-4, SCF, Flt-3L, IL3, IL6, G-CSF [91, 93] Heart Cardiomyocytes GATA-4, Nkx2.5 [72, 73] Ascorbic Acid [69] , 5-aza-2'-deoxycytidine [73] PLLA /PLGA [71] , Fibrin-coated dishes [66] Bone Osteoblasts Cbfa1/Runx2, osteocalcin, bone sialoprotein [81] [82] [83] ␤-glycerophosphate, ascorbic acid, dexamethasone [82] PDLLA [82] Cartilage Chondrocytes Sox9, GAG [84] BMP-2 [85] , TGF-␤1 (mESCs) [86] PEG hydrogel [86] Blood vessels Endothelial cells VE-cadherin, CD31, vWF [91, 92, 96, 97] VEGF [92] Alginate [98] , PLGA [99] Pancreatic ␤-islets Pdx1 [111] , Ngn3 [112] , Nkx6.1 [112] Activin A, RA [110] Liver Hepatocytes HNF-3␤, indocyanine green uptake [117] FGF-4, hepatocyte growth factor [117] 2D and 3D collagen scaffolds [118] The [21] . Uncoated EBs have also been cultured in traditional stirred vessels [22] as well as rotating wall bioreactors [23] . Perfusion has been shown to enhance cell yield in adherent hESC cultures [24] [32] , and TGF-␤ superfamily members such as Activin and Nodal seem to inhibit neuroectodermal specification [33] . However, the specific factors required for ectodermal differentiation are unclear given that both PI3K and TGF-␤ signalling promote maintenance of hESCs in the undifferentiated state [12, 34] [37] . More recently full thickness tissue engineered skin has been reconstructed using autologous keratinocytes and fibroblasts with collagen-GAG substrates [4] . Further improvements have been made to these systems via incorporation of melanocytes to provide pigmentation [38] , addition of endothelial cells to promote vascularization [39] , and genetic modification of keratinocytes to induce expression of vascular growth factors [40] . There are now several tissue engineered skin products available for treatment of burns and/or chronic wounds (reviewed in [41] [43] . Experiments using mESCs have identified factors such as BMP-4 that may improve differentiation efficiency [44] , though this method may not be applicable to human lines given their propensity to generate trophoblasts in response to BMP-4 [30] . The expansion potential of hESC-derived keratinocytes has also been questioned [45] 
Mesodermal tissues
Mesodermal cells comprise skeletal, dermal, muscle and connective tissue, as well as components of the circulatory and excretory systems. During gastrulation, as cells migrate through the primitive streak, mesendoderm cells diverge to the endoderm and mesoderm germ layers. Mesoderm derivatives of particular therapeutic interest include cardiac muscle, bone, cartilage, blood, and vascular endothelial cells. Few early human mesodermal markers or induction factors have been identified to date.
However, studies of mouse embryogenesis have shown that both Wnt and nodal signalling are required for formation of the primitive streak [62] , and BMP-4 signalling is necessary for gastrulation and mesoderm formation [63] [64] . [65] , and fibrin-coated dishes can be used to culture cardiomyocyte sheets that can be transplanted with minimal cell loss [66] .
. Finally, the transcription factor brachyury (T) is specific to early mesoderm cells and is commonly used to identify and characterize these cells as they undergo an epithelial-to-mesenchymal transition
Heart
Various progenitor cell types, including bone marrow cells [67] and adult cardiac progenitors [68] [89, 90] 
Circulatory system
Blood cells and the endothelium arise from a common progenitor during embryogenesis, and similar environmental stimuli have been shown to stimulate haematopoietic and endothelial differentiation from hESCs [91, 92] [91] [92] [93] . Recently a scaleable suspension culture process using stromal induction was developed for the production of red blood cells from hESCs [94] [102] . In mice, high levels of Nodal preferentially select for endoderm over mesoderm [103] . A recent study demonstrated that Activin A, another a member of the TGF-␤ superfamily, commits hESC differentiation to definitive endoderm in low-serum conditions [104] . In addition, the temporal sequence of gene expression during hESC differentiation to definitive endoderm mimics the vertebrate gastrulation process. Subsequent work has determined that repression of PI3K signalling is also necessary to generate definitive endoderm from hESCs [32] .
Various protocols have been used to generate haematopoietic progenitors from hESCs, including EB differentiation in the presence of cytokines (i.e. BMP-4) and induction using stromal co-cultures
General challenges in deriving definitive endoderm include identifying and purifying the resulting cells. Although Sox17 [105] and HNF3␤/FoxA2 [106] [117] . In addition, 3D collagen scaffolds may spatially replicate the in vivo microenvironment for differentiation of hESCs to hepatic cells [118] . Hepatocytes can be identified by expression of transcription factors such as hepatocyte nuclear factor-3␤ (HNF-3␤), and hepatic functionality can be assessed using indocyanine green uptake, glycogen storage, ALB/CK-18 co-expression and urea production, among other factors [117] . However, the differentiation efficiency must be improved in order to develop clinically usable hepatocytes from hESCs. Recently, progress has been made in the development of a human hepatocyte-like cell line from hESCs containing GFP driven by the ␣ 1-antitrypsin promoter [119] . mESCs have recently been used to develop implanted bioartificial liver devices which improved liver function in mice [120] . [91, 92, 96, 97] Endoderm ␤-islets Moderate Defined Definitive endoderm only (CXCR4) [113] Hepatocytes Not defined Yes Not demonstrated [117, 118] executed successfully, implementation at a reasonable scale would be impossible [121, 122] . 
